THE PDGFR/SRC SIGNALING PATHWAY-TARGETED THERAPY WITH NOVEL TUSC2-NANOPARTICLES AND TYROSINE KINASE INHIBITORS FOR HUMAN LUNG CANCER

被引：0
|
作者：
Wu, Quanglin [1 ]
Liu, Qing [1 ]
Sakai, Ryo [1 ]
Hangauer, David [2 ]
Roth, Jack [1 ]
Ji, Lin [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Lung cancer; PDGFR-Src signaling pathway; TUSC2 (FUS1)-nanoparticle; PDGFR and Src kinase inhibitors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.05-003
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [21] Inhibitors of the epidermal growth factor receptor tyrosine kinase: targeted therapy hits the Bullseye in patients with non-small-cell lung cancer
    Kris, MG
    LUNG CANCER, 2004, 45 : S6 - S6
  • [22] Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
    Liu, Yi-Nan
    Tsai, Meng-Feng
    Wu, Shang-Gin
    Chang, Tzu-Hua
    Tsai, Tzu-Hsiu
    Gow, Chien-Hung
    Chang, Yih-Leong
    Shih, Jin-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (06) : 1609 - 1624
  • [23] Bone-targeted pyrido[2,3-d]pyrimidin-7-ones:: Potent inhibitors of Src tyrosine kinase as novel antiresorptive agents
    Vu, CB
    Luke, GP
    Kawahata, N
    Shakespeare, WC
    Wang, YH
    Sundaramoorthi, R
    Metcalf, CA
    Keenan, TP
    Pradeepan, S
    Corpuz, E
    Merry, T
    Bohacek, RS
    Dalgarno, DC
    Narula, SS
    van Schravendijk, MR
    Ram, MK
    Adams, S
    Liou, S
    Keats, JA
    Violette, SM
    Guan, W
    Weigele, M
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 3071 - 3074
  • [24] SYNERGISTIC ANTITUMOR ACTIVITY OF THE COMBINATION OF THE MULTI-TARGETED TYROSINE KINASE INHIBITOR SORAFENIB AND OF EGFR INHIBITORS IN HUMAN COLON AND LUNG CANCER CELL
    Troiani, T.
    Martinelli, E.
    Morgillo, F.
    Orditura, M.
    De Vita, F.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 51 - 51
  • [25] TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia
    Gong, Ping
    Angelini, Daniel J.
    Yang, Shiqi
    Xia, Guanjun
    Cross, Alan S.
    Mann, Dean
    Bannerman, Douglas D.
    Vogel, Stefanie N.
    Goldblum, Simeon E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) : 13437 - 13449
  • [26] Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy
    Onder, Ferah Comert
    Siyah, Pinar
    Durdagi, Serdar
    Ay, Mehmet
    Ozpolat, Bulent
    RSC MEDICINAL CHEMISTRY, 2022, 13 (07): : 840 - 849
  • [27] Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines
    Martinelli, E.
    Troiani, T.
    Laus, G.
    Pepe, S.
    Ciardiello, F.
    EJC SUPPLEMENTS, 2006, 4 (12): : 123 - 123
  • [28] Facile synthesis of biocompatible MoSe2 nanoparticles for efficient targeted photothermal therapy of human lung cancer
    Zhong, Chunlei
    Zhao, Xin
    Wang, Lijiang
    Li, Yunxia
    Zhao, Yingying
    RSC ADVANCES, 2017, 7 (12): : 7382 - 7391
  • [29] Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer
    Jin, Junfei
    Xiong, Ying
    Cen, Bo
    ANTI-CANCER DRUGS, 2017, 28 (10) : 1141 - 1149
  • [30] Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
    Phan, Ai N. H.
    Hua, Tuyen N. M.
    Kim, Min-kyu
    Vo, Vu T. A.
    Choi, Jong-Whan
    Kim, Hyun-Won
    Rho, Jin Kyung
    Kim, Ki Woo
    Jeong, Yangsik
    ONCOTARGET, 2016, 7 (34) : 54702 - 54713
12345